Market Scope

NeuroVision Acquires Durin Life Sciences to Advance Neurological Diagnostics: bit.ly/43g2CQk

IOP-Lowering Goggles Gain US FDA 510(k) Nod for Wireless Upgrade: bit.ly/4nzKoCT

American Medical Association (AMA) Urges Physician Protections Against AI Deepfake Impersonation: bit.ly/43f19K5

Mexico Approves Zeiss’ Artevo 850 OR Microscope and Micor 700 Cataract Handpiece: bit.ly/42HFAla

Q1-2026 Ophthalmic Revenue Roundup for Tarsus, Sight Sciences, and Lenz: bit.ly/3RfrYew

US FDA Commissioner Makary Resigns After Rocky Year in Top Job: bit.ly/4wwX4i1

US FDA Accepts Opus’ LCA5 Gene Therapy Candidate into New Rare Disease Program: bit.ly/4dAvRDj

Kubota Vision, Laboratoires Kôl Team Up on Compassionate Use of Stargardt Candidate: bit.ly/48X1e8G

Novelty Nobility Taps AGC Biologics to Help Advance Bispecific Retinal Candidate: bit.ly/4ffa59v

Xbrane Resubmits BLA to US FDA for Lucentis Biosimilar: bit.ly/4uJW88f

Bausch + Lomb Launches Bi-Blade+ Dual-Port Vitrectomy Cutter in Europe: bit.ly/48SHLGb

Quarterly Ophthalmic Revenue Roundup for Alcon, Amgen, Hoya, Ocular Therapeutix, and Xbrane: bit.ly/48S6g6e

Bayer to Acquire Perfuse Therapeutics in Deal Worth Up to $2.45 Billion: bit.ly/4dfpFzl

EMA Grants PRIME Designation to Ray Therapeutics’ Optogenetic RP Candidate: bit.ly/4uuZCLK

Formosa, Singapore Eye to Explore New Treatments for Corneal, Ocular Surface Disease: bit.ly/4d54srU

US FDA Gives Green Light to Trial of LayerBio’s OcuRing-K for Post-op Inflammation and Pain: bit.ly/4cXLwN3

BVI Announces Full CE Marking for its Virtuoso Platforms: bit.ly/4diRwQp

Belite Bio Initiates Rolling NDA Submission for Oral Tinlarebant in Stargardt: bit.ly/4tSMWOO

Ligand to Acquire Xoma, Including its Vabysmo Royalties, for $739 Million: bit.ly/48DDaHG

Scientists Deliver Healthy Mitochondria to Sick Cells, Including Eye Cells: bit.ly/48EQ9sI